NEURL Inhibitors

The term NEURL inhibitors encompasses a diverse group of chemicals that target various cellular processes and pathways indirectly associated with NEURL1 function. NEURL1 is a ubiquitin ligase implicated in the ubiquitination of proteins for degradation, which is a fundamental process for protein quality control and signaling regulation. The chemicals listed in the table above modulate proteostasis pathways, such as proteasome-mediated degradation and autophagy, or signaling pathways like Notch, MAPK/ERK, and JNK. By influencing these pathways, these compounds can indirectly affect the functional outcomes of NEURL1 activity.Proteasome inhibitors like MG132 and lactacystin prevent the breakdown of ubiquitinated proteins, which could lead to an accumulation of substrates that NEURL1 targets for degradation. Autophagy inhibitors, including chloroquine, 3-MA, and bafilomycin A1, can also lead to the buildup of ubiquitinated proteins, thereby altering the cellular environment in which NEURL1 operates. These inhibitors can cause a wider disruption in cellular homeostasis, affecting the degradation and recycling of proteins that NEURL1 may ubiquitinate.

Furthermore, compounds like DAPT and LY411575 are γ-secretase inhibitors that affect the Notch signaling pathway. NEURL1 has been implicated in the regulation of Notch receptor and ligand ubiquitination, which is crucial for the activation and modulation of this pathway. By inhibiting γ-secretase, these compounds can modify Notch receptor processing and signaling, thus indirectly influencing the role of NEURL1. Lastly, kinase inhibitors such as U0126, PD98059, SB203580, and SP600125 target the MAPK/ERK and JNK pathways. These pathways are involved in cellular responses to developmental cues and stress, and NEURL1 may have a role in these processes. By modulating these pathways, kinase inhibitors can indirectly affect NEURL1's activity. These chemicals represent a broad class of compounds that, by altering key cellular pathways, can influence the activity of NEURL1 without directly binding to the protein or its immediate substrates.